Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
0.80085
+0.0243 (3.14%)
May 13, 2026, 11:53 AM EDT - Market open
Celularity Market Cap
Celularity has a market cap or net worth of $23.09 million as of May 13, 2026. Its market cap has decreased by -34.33% in one year.
Market Cap
23.09M
Enterprise Value
90.93M
1-Year Change
-34.33%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since August 8, 2019, Celularity's market cap has decreased from $352.19M to $23.09M, a decrease of -93.44%. That is a compound annual growth rate of -33.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2026 | 22.39M | -29.16% |
| Dec 31, 2025 | 31.61M | -32.41% |
| Dec 31, 2024 | 46.77M | -1.00% |
| Dec 29, 2023 | 47.24M | -74.75% |
| Dec 30, 2022 | 187.07M | -70.41% |
| Dec 31, 2021 | 632.14M | 59.91% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Barinthus Biotherapeutics | 27.37M |
| ABVC BioPharma | 26.19M |
| Serina Therapeutics | 26.07M |
| Jasper Therapeutics | 25.93M |
| Longeveron | 24.75M |
| Marker Therapeutics | 24.34M |
| Vistagen Therapeutics | 24.19M |
| Allarity Therapeutics | 23.96M |